Harrow, Inc.

Key metrics

Financial performance

Over the last 9 fiscal years Harrow, Inc.'s revenue grew from $19.94M to $272.30M, a compound annual growth rate of 33.7%. Net profit margin expanded from -95.7% to -1.9% over the same period - every figure below comes from the company's audited annual filings.

Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.

Key statistics

Latest filings

Browse the full filing history (849 filings)

Recent press releases

• Harrow to Present at William Blair’s 46th Annual Growth Stock Conference2026-05-27

  Harrow to Present at William Blair’s 46th Annual Growth Stock Conference | Harrow, Inc.

• Harrow Announces First Quarter 2026 Financial Results2026-05-11

  Harrow Announces First Quarter 2026 Financial Results | Harrow, Inc.

• Harrow To Report First Quarter 2026 Financial Results After Market Close on May 11, 20262026-05-11

  Participants can access the live webcast of Harrow’s presentation on the “Investors” page of Harrow’s website. A replay of the webcast will be available on the Company’s website for one year.

• Harrow Announces the Issuance of J-Code for IOPIDINE® 1%2026-04-16

  Harrow Announces the Issuance of J-Code for IOPIDINE® 1% | Harrow, Inc.

• Harrow Announces Pricing of $50.0 Million Offering of Senior Unsecured Notes Due 20302026-03-24

  Harrow Announces Pricing of $50.0 Million Offering of Senior Unsecured Notes Due 2030 | Harrow, Inc.

Similar companies

The largest companies sharing Harrow, Inc.'s SEC industry classification (pharmaceutical preparations).